S. Martel et Pc. Carre, PULMONARY PATHOLOGY IN HEART, LIVER AND K IDNEY-TRANSPLANTATION IN THE ADULT, Revue des maladies respiratoires, 13(5), 1996, pp. 57-70
Currently transplantation constitutes the only treatment for terminal
heart, liver or renal failure. Post-transplantation complications rema
in numerous and sometimes fatal. The rejection of the organ, acute or
chronic, and secondary infections due to immunosuppression are the mos
t frequent complications that are observed. Added to this are the comp
lications of the surgery itself and also the non-infectious complicati
ons of the immunosuppressive drugs. Pulmonary complications contribute
an important factor to the post-graft morbidity and mortality. The ma
jority of heart and liver transplants develop pulmonary complications
principally in the first six months after graft. The immediate post-op
erative complications such as atelectasis, pleural effusion and pulmon
ary oedema are the most frequent but the infectious complications are
much the most serious and are responsible for a significant part of th
e mortality. In renal transplantation pulmonary complications are abov
e all infectious and are much less common than in cardiac or hepatic t
ransplantation. An early diagnosis of the type of complication constit
utes a major prognostic factor in immunodepressed patients. Thus, the
practising pneumologist must thoroughly know the principal respiratory
complications of solid organ transplant.